Pfizer's HYMPAVZI FDA label expansion | Lucid Diligence Brief
Pfizer’s HYMPAVZI FDA label expansion covers children 6–11 and patients ≥12…
Rare Diseases Today—May 21, 2026
This week’s Rare Diseases update highlights regulatory progress, orphan…
Hematology Today—May 18, 2026
This week’s Hematology update highlights regulatory progress, clinical…
Hematology Today—March 30, 2026
This week’s Hematology update highlights regulatory progress, evolving…
Hematology Video Recap—February 9, 2026
Hematology biweekly video highlighting regulatory actions across cancer and…
Rare Disease Video Recap—January 15, 2026
This Rare Disease Video Recap highlights major regulatory decisions and…